APOB and coronary artery disorder: Interestingly, Lp(a) levels persisted as a risk factor in nearly all tested subgroups—including patients with concomitant CAD—suggesting that perhaps the oxidized phospholipids or other moiety on the Lp(a) particle act via different pathways than other apoB‐containing lipoproteins.